Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-122,800
Closed -$13.9M 3013
2024
Q3
$13.9M Buy
122,800
+25,800
+27% +$3.07M 0.03% 377
2024
Q2
$12M Sell
97,000
-195,400
-67% -$25.2M 0.03% 427
2024
Q1
$38.6M Buy
292,400
+143,300
+96% +$17.7M 0.07% 138
2023
Q4
$16.3M Sell
149,100
-85,100
-36% -$8.83M 0.03% 407
2023
Q3
$24.1M Buy
+234,200
New +$25.2M 0.04% 278

Other funds holding MRK

GTS Securities's MRK Position: Q2 2026 in Review

GTS Securities reduced its Merck (MRK) stake by 41% in Q2 2026, selling an estimated $450K and leaving 5,462 shares worth $702K. The position accounts for 0.01% of the portfolio, ranked #575.

GTS Securities first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.61M in Q4 2023. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GTS Securities held 5,462 shares of Merck worth $702K as of Q2 2026.
  • GTS Securities sold 3,843 Merck shares in Q2 2026, an estimated $450K.
  • Merck made up 0.01% of GTS Securities's portfolio in Q2 2026, its #575 holding.
  • GTS Securities first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • GTS Securities's Merck position peaked at $4.61M in Q4 2023.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.